I am grateful for the opportunity to advance my research on repurposing innovation through a grant from the Adlerbert Research Foundation. The project โ๐๐ฆ๐ฑ๐ถ๐ณ๐ฑ๐ฐ๐ด๐ช๐ฏ๐จ ๐๐ณ๐ถ๐จ๐ด: ๐๐ณ๐ช๐ฆ๐ฏ๐ฅ ๐ฐ๐ณ ๐๐ฐ๐ฆ ๐ง๐ฐ๐ณ ๐๐ถ๐ด๐ต๐ข๐ช๐ฏ๐ข๐ฃ๐ญ๐ฆ ๐๐ฆ๐ข๐ญ๐ต๐ฉ๐ค๐ข๐ณ๐ฆ ๐๐ฆ๐ท๐ฆ๐ญ๐ฐ๐ฑ๐ฎ๐ฆ๐ฏ๐ต?โ studies whether and to what extent existing medicines are repurposed, i.e. used in disease areas other than the originally intended ones. A particular focus on my empirical research in this project is to explore whether drug repurposing is used to address unmet health needs, particularly needs prevalent in developing countries. A further important aspect of this project is to study when and how firms engage in repurposing activities and use repurposing as an innovation strategy.
